ALBUQUERQUE, N.M. — Heel on Thursday announced the launch of the Reboost cold and flu product line and new packaging for the Traumeel pain relief product line. The Reboost product line brings together four of the company’s cold, cough and flu products under a single brand that has been specifically designed to speak to the consumer in a retail environment.
“These new options will help retailers better respond to increasing consumer interest in and demand for medicines with natural ingredients, including homeopathic products that provide relief with rare side effects,” stated Cliff Clive, Heel CEO. “As a trusted name in homeopathic medicines, Heel is committed to meeting the needs of both retailers and consumers by offering medicines with an impressive safety profile.”
The Reboost line of products includes nasal spray (0.68 fluid ounces) for the temporary relief of minor nasal symptoms, throat spray (0.68 fluid ounces) for the temporary relief of minor pain from sore throat and pain from canker sores, tablets (100 ct) for the temporary relief of flu symptoms and cough syrup (4.23 fluid ounces) for cough and chest congestion relief. This line of products will replace previous Heel products Nectadyn, Sinusin and Vinceel.
The redesigned Traumeel packaging, with a new vertical orientation, better maximizes shelf space for retailers and generates dramatic profitability gains per foot of shelf space, the company reported. The new packaging will also contain a new formula of Traumeel that has been shown to provide pain relief for ankle sprain that is equivalent to prescription-only diclofenac topical.
These changes are set to debut on store shelves beginning September 2013.